Literature DB >> 7853956

Gene therapy and immune restoration for HIV disease.

S H Bridges1, N Sarver.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7853956     DOI： 10.1016/s0140-6736(95)90407-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  New approach for inhibiting Rev function and HIV-1 production using the influenza virus NS1 protein.

Authors:  X Y Qian; Z Y Chen; J Zhang; A B Rabson; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

2.  Inhibition of HTLV-I induction and virus-induced syncytia formation by oligodeoxynucleotides.

Authors:  N Miyano-Kurosaki; Y Koyanagi; M Mizuguchi; S Ohki; K Makino; N Yamamoto
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

3.  Transfer of human CD4(+) T lymphocytes producing beta interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infection.

Authors:  V Vieillard; S Jouveshomme; N Leflour; E Jean-Pierre; P Debre; E De Maeyer; B Autran
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Multigene antiviral vectors inhibit diverse human immunodeficiency virus type 1 clades.

Authors:  A Gervaix; X Li; G Kraus; F Wong-Staal
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  Transduction of CD34+ hematopoietic progenitor cells with an antitat gene protects T-cell and macrophage progeny from AIDS virus infection.

Authors:  M Rosenzweig; D F Marks; D Hempel; J Lisziewicz; R P Johnson
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication.

Authors:  M L Bonyhadi; K Moss; A Voytovich; J Auten; C Kalfoglou; I Plavec; S Forestell; L Su; E Böhnlein; H Kaneshima
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

7.  Co-packaging of sense and antisense RNAs: a novel strategy for blocking HIV-1 replication.

Authors:  S F Ding; J Noronha; S Joshi
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

8.  Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).

Authors:  Pheroze Joshi; Vinayaka R Prasad
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

9.  Systemic T cell-independent tumor immunity after transplantation of universal receptor-modified bone marrow into SCID mice.

Authors:  K M Hege; K S Cooke; M H Finer; K M Zsebo; M R Roberts
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

10.  Low autocrine interferon beta production as a gene therapy approach for AIDS: Infusion of interferon beta-engineered lymphocytes in macaques chronically infected with SIVmac251.

Authors:  Wilfried Gay; Evelyne Lauret; Bertrand Boson; Jérome Larghero; Franck Matheux; Sophie Peyramaure; Véronique Rousseau; Dominique Dormont; Edward De Maeyer; Roger Le Grand
Journal:  Retrovirology       Date:  2004-09-25       Impact factor: 4.602
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.